Leproust Emily M. Insider Trades & Stock Holdings

Chief Executive Officer · Twist Bioscience Corporation · Latest filing Oct 5, 2026

Leproust Emily M., Chief Executive Officer at Twist Bioscience Corporation has 6 Form 4 trades on file since Sep 17, 2026. Open-market activity: 0 purchases ($0) and 6 sales ($67.22M), net -$67.22M. Latest filing: disposed of 4.55K shares of $TWST on Oct 5, 2026 at $202.15.

Trades on file

6

Open-market bought

$0

Open-market sold

$67.22M

Net open-market

-$67.22M

Latest filing

Oct 5, 2026

All insider trades by Leproust Emily M.

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 5, 2026	$TWST	Sell (Open-market sale) 10b5-1	4.55K	$202.15	$919.37K			-25.9%			Chief Executive Officer		—
Oct 2, 2026	$TWST	Sell (Open-market sale) 10b5-1	45.74K	$188.88	$8.64M			-15.3%			Chief Executive Officer		—
Oct 1, 2026	$TWST	Sell (Open-market sale) 10b5-1	655	$200	$131K			-19.1%			Chief Executive Officer		—
Sep 24, 2026	$TWST	Sell (Open-market sale) 10b5-1	5.20K	$177.38	$922.91K			+2.2%			Chief Executive Officer		—
Sep 21, 2026	$TWST	Sell (Open-market sale)	1.69K	$165.49	$279.18K			+8.3%			Chief Executive Officer		—
Sep 17, 2026	$TWST	Sell (Open-market sale) 10b5-1	356.55K	$157.99	$56.33M			+18.3%			Chief Executive Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Leproust Emily M. traded

• $TWST

Frequently asked questions

Has Leproust Emily M. been buying or selling stock?

Leproust Emily M. has 0 open-market purchases and 6 open-market sales on file, net -$67.22M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Leproust Emily M.'s latest insider trade?

disposed of 4.55K shares of $TWST on Oct 5, 2026 at $202.15.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.